Rossari Biotech: Management Call on Acquisition of Tristar Intermediaries
Conference Call with Rossari Biotech Management and Analysts on the company's acquisition of Tristar Intermediaries. Listen to the full call transcript.19-07-2021
19-07-2021
Rossari Biotech buys Tristar Intermediates for 120 crore
Rossari Biotech, a speciality chemicals company, has acquired Tristar Intermediates for an enterprise value of 120 crore.As per the agreement signed,18-07-2021
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analysts/Institutional Investor Meet/Con. Call Update18-07-2021
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Rossari Biotech Limited has informed the Exchange regarding Allotment of 113150 Shares.18-07-2021
Rossari Biotech Ltd - 543213 - Grant Of Options Under Rossari Employee Stock Option Plan - 2019
Rossari Biotech Limited has informed the Exchange regarding Grant of 4000 Options.17-07-2021
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Acquisition
Rossari Biotech Limited has agreed to acquire Rossari Personal Care Products Private Limited17-07-2021
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Acquisition
Rossari Biotech Limited has agreed to acquire Tristar Intermediates Private Limited17-07-2021
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Rossari Biotech Limited has informed the Exchange regarding a press release dated July 17, 2021, titled "Rossari to acquire Tristar Intermediates".17-07-2021
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Credit Rating
Intimation of Credit Rating14-07-2021
Rossari Biotech Ltd - 543213 - Shareholding for the Period Ended June 30, 2021
Rossari Biotech Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here13-07-2021